Cepharanthine hydrochloride inhibits prostate cancer progression by modulating gut microbiota and metabolites
This study is the first to explore the potential mechanisms of gut microbiota-mediated CH treatment for prostate cancer, providing a scientific basis for the application of CH in PCa therapy.
Authors
- Zongming Dong
- Bishao Sun (ORCID: https://orcid.org/0000-0003-3962-5043)
- Peng He (ORCID: https://orcid.org/0009-0001-1062-9166)
- Yongming Jia (ORCID: https://orcid.org/0000-0002-0157-6939)
- Hui Li (ORCID: https://orcid.org/0000-0002-7879-1792)
- Ji Zheng (ORCID: https://orcid.org/0000-0002-4636-0998)
- Xing Luo
- Jingzhen Zhu
Institutions
- Army Medical University (CN)
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Affiliated Hospital of North Sichuan Medical College (CN)
- Xinqiao Hospital (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-08-13
- DOI
- https://doi.org/10.3389/fphar.2025.1627656
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Sichuan Province